Institutional investors purchased a net $2.7 million shares of TROV during the quarter ended March 2015, and now own 30.62% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BRIDGER MANAGEMENT LLC Bought 440.0 Thousand shares of Trovagene Inc